Molecular Epidemiological Insights into Colistin-Resistant and Carbapenemases-Producing Clinical Klebsiella pneumoniae Isolates.

PURPOSE: Carbapenemases-producing Klebsiella pneumoniae are challenging antimicrobial therapy of hospitalised patients, which is further complicated by colistin resistance. This study describes molecular epidemiological insights into colistin-resistant and carbapenemases-producing clinical K. pneumoniae. PATIENTS AND METHODS: Cultures collected from 26 hospitalised patients during 2014-2017 in the main hospital in Molise Region, central Italy, were characterized. The minimum inhibitory concentration for 19 antibiotics was determined, including carbapenems and colistin. Prevalence of resistance-associated genes was investigated through PCR, detecting bla KPC, bla GES, bla VIM, bla IMP, bla NDM, bla OXA-48, bla CTX-M, bla TEM, bla SHV, and mcr-1,2,3,4,5,6,7,8. The mgrB gene was also analysed in colistin-resistant strains by PCR and sequencing assays. K. pneumoniae were typed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).
RESULTS: Twenty out of 26 K. pneumoniae were phenotypically resistant to carbapenems and 19 were resistant to colistin. All isolates harbored bla KPC, and bla SHV, bla TEM and bla VIM were further the most common resistance-associated genes. In colistin-resistant strains, mcr-1,2,3,4,5,6,7,8 variants were not detected, while mutations and insertion elements in mgrB were observed in 68.4% (n=13) in 31.6% (n=6) isolates, respectively. PFGE revealed 12 clusters and 18 pulsotypes at 85% and 95% cut-off, while the Sequence Types ST512 (n=13, 50%), ST101 (n=10, 38.5%), ST307 (n=2, 7.7%) plus a novel ST were detected using MLST.
CONCLUSION: All K. pneumoniae showed a multidrug-resistant phenotype, particularly to carbapenems and colistin. According to national data, bla KPC was the prevailing carbapenemase, followed by bla VIM, while bla TEM and bla SHV were among the most frequent beta-lactamases. Consistent with previous reports in Italy, ST512 was the most common clone, particularly during 2014-15, whilst ST101 became dominant in 2016-17. Colistin resistance was mainly associated with deleterious mutations and transposon in the mgrB gene. Improvements of surveillance, compliance with infection prevention procedures and antimicrobial stewardship are essential to limit the spread of resistant K. pneumoniae.

Introduction

Klebsiella pneumoniae is the most clinically relevant Klebsiella species.1 The 2011–2012 Point Prevalence study of the European Centre for Disease Prevention and Control identified K. pneumoniae causing 6.8% of hospital-acquired infections (HAIs), which represented the second most frequent Enterobacteriaceae after Escherichia coli.2 In 2005, almost all European regions were carbapenem-resistant K. pneumoniae (CR-Kp) free. From 2005 to 2015, CR-Kp has emerged in several countries, reaching rates of 40–60%.3 In the TOTEM study, CR-Kp was classified as the most critical antimicrobially resistant pathogen and a leading cause of nosocomial infections, mainly in intensive care units (ICUs).4 Furthermore, among 5331 bacteremia cases due to carbapenemase-producing Enterobacteriaceae, 96.8% was attributed to K. pneumoniae.5 At EU/EEA level, in 2017, 34% of K. pneumoniae notified to the European Antimicrobial Resistance Surveillance Network were resistant to at least one of the antimicrobial groups under surveillance, including carbapenems.6

Carbapenemases production, particularly KPC, represents the most prevalent mechanism for carbapenems resistance in K. pneumoniae,5,7 but the carbapenemases GES, NDM, IMP, VIM, and OXA-48 can also be involved.8 K. pneumoniae carrying the gene blaKPC are endemic in Italy since nearly 90% of CR-Kp are KPC producers, followed by blaVIM (9.2%) and blaOXA-48 (1.3%).3,9,10 In K. pneumoniae, extended spectrum beta-lactamases (ESBLs) have been also detected, being involved in oximino-cephalosporin resistance and able to hydrolyze beta-lactams.11 During 1990–2000, K. pneumoniae has become the major ESBL-carrying pathogen in hospital outbreaks, mostly carrying blaTEM and blaSHV.12

The increasing prevalence of multidrug-resistant (MDR) Gram-negative bacteria has led to re-introduction of colistin, especially for infections sustained by K. pneumoniae.4 Nevertheless, in the last years, colistin resistance has also emerged in CR-Kp with rates as high as 36%.3,13,14 In this case, resistance is due to structural modifications of lipopolysaccharide (LPS) that is the target for colistin. Resistance could be attributed to mgrB inactivation by down-regulation of the Pmr system involved in LPS modification, neutralizing the negative charge and decreasing colistin binding,15,16 or through plasmid-mediated mcr (mcr-1,2,3,4,5,6,7,8 variants).17–23

Management of CR-Kp infections is associated with long hospitalizations and poor outcomes1,14 and complicated by MDR emergence, which severely limits antimicrobial treatment options.14 Since K. pneumoniae is among the most frequent agents in nosocomial settings,8 identification of outbreaks due to MDR strains is crucial. In this scenario, molecular typing enabling strains comparison is required for detecting epidemics and tracking infection sources and factors involved in the transmission.24 For K. pneumoniae molecular characterization, the foremost approaches rely on pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) systems.25

In this study, clinical K. pneumoniae isolated in the main hospital in Molise Region, central Italy, were characterized to evaluate MDR patterns, genetic differences and relationships, and prevalence of carbapenem resistance determinants, as well as to elucidate the mechanisms involved in colistin resistance.

Materials and Methods

K. pneumoniae Cultures and DNA Extraction

Twenty-six K. pneumoniae cultures isolated within the “Alert Organism” surveillance system during 2014–2017 were collected from the main hospital for acute care in Molise Region, central Italy. The hospital at the time of the study had a total of 336 beds, 320 for acute care and 16 for ICU.26 Additionally, there were 19 total wards: ten of medicine and surgery specialties, four of pediatrics and two of ICU specialties, followed by single wards of gynecology/obstetrics, geriatrics, psychiatry, rehabilitation, and mixed specialties.

The selection criteria for the tested strains were non-replicates cultures, and a KPC phenotype evaluated with the Matrix-Assisted Laser Desorption Ionization-Time-Of-Flight Mass Spectrometry (MALDI-TOF) assay, as reported by the hospital laboratory. K. pneumoniae cultures were mostly recovered from aspirated bronchial (n=9, 35.0%) samples, urine (n=6, 23%), rectal swab (n=4, 15.4%), and blood cultures (n=3, 11.5%) (Table 1). Fifteen (57.7%) isolates were from patients admitted to ICU: 60% male, overall mean age 73±12.6 years (median 78.5, range 44–89 years). Clinical specimens were cultured and purified on McConkey agar plates (Biolife, Milan, Italy) incubated at 37°C overnight. DNA was extracted using Maxwell® 16 Cell DNA Purification Kit (Promega, Milan, Italy).

Table 1

Patient's Clinical Data and Characteristics of Analyzed Strains

Strain	Isolation date	Age	Gender	Sample	Ward	Clinical Data and Risk Factors
KP3	16/08/2014	85	M	Blood culture	Medicine	Infection/sepsis (fever)
KP4	18/08/2014	79	M	Bronchial aspirate	ICU	Infection Invasive procedures
KP5	30/10/2014	63	M	Urine	ICU	Urinary tract infection
KP6	20/10/2014	40	F	Urine	Urology	Urinary tract infection
KP7	19/11/2014	75	M	Prosthetic liquid	Orthopaedic	Infection/sepsis
KP8	17/11/2014	84	M	Bronchial aspirate	ICU	Pulmonary infection Invasive procedures
KP9	09/12/2014	76	M	Bronchial aspirate	ICU	Pulmonary infection Invasive procedures
KP10	14/12/2014	70	M	Blood culture	Infectious disease	Infection/sepsis
KP11	15/12/2014	63	M	Blood culture	Urology	Infection/sepsis
KP12	05/01/2015	85	F	Urine culture	ICU	Urinary tract infection
KP14	05/01/2015	74	M	Bronchial aspirate	ICU	Infection/sepsis Invasive procedures
KP18	12/01/2015	75	F	Bronchial aspirate	ICU	Pulmonary infection Invasive procedures
KP19	12/01/2015	81	M	Bronchial aspirate	ICU	Pulmonary infection
KP25	25/01/2016	56	M	Ulcer swab	Diabetology	Diabetic foot with amputation
KP27	01/02/2016	60	M	Bronchial aspirate	ICU	Urinary tract infection
KP28	29/02/2016	59	M	Urine culture	ICU	Urinary tract infection Invasive procedures
KP29	02/03/2016	71	F	Rectal swab	ICU	Colonization
KP31	11/09/2016	50	M	Rectal swab	ICU	Colonization
KP32	20/02/2017	82	F	Urine culture	Infectious disease	Urinary tract infection
KP34	06/03/2017	56	M	Bronchial aspirate	ICU	Pulmonary infection
KP36	03/04/2017	78	F	Bronchial aspirate	ICU	Urinary tract infection Invasive procedures
KP39	09/11/2017	58	F	Stent	Nephrology	Not available
KP40	06/11/2017	59	F	Urine	Nephrology	Urinary tract infection Invasive procedures
KP41	07/11/2017	78	M	Cyst	Orthopaedic	Not available
KP42	07/11/2017	87	M	Rectal swab	ICU	Colonization
KP43	19/12/2017	57	M	Rectal swab	ICU	Colonization

Antimicrobial Susceptibility Testing

The susceptibility to nineteen antimicrobials was evaluated by the hospital Microbiology laboratory using BD Phoenix™ Automated Microbiology System (Becton Dickinson Diagnostic Systems, Sparks, United States). The minimum inhibitory concentrations (MICs) were calculated for imipenem, ertapenem and meropenem (carbapenems); ampicillin, amoxicillin-clavulanate, piperacillin and piperacillin-tazobactam; ceftazidime, cefuroxime and cefotaxime; amikacin and gentamicin; ciprofloxacin and levofloxacin; fosfomycin, trimethoprim-sulfamethoxazole, tigecycline, and tobramycin. The microdilution method was used for colistin (polymyxin) MIC determination. Results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing breakpoints.27

Detection of Resistance-Associated Genes

Genes involved in carbapenems resistance were detected through single PCR assays, targeting blaKPC, blaGES, blaIMP, blaVIM, blaOXA-48 and blaNDM-1 genes.28,29 Amplifications were performed in 25 μL volume with 2 μL DNA template, 1X PCR Master Mix (Promega Corporation) and 1 µM of each primer. Target genes were amplified at specific conditions: 94°C 2 mins; 35 cycles: 94°C 1 min, 45°C (blaIMP)/52°C (blaKPC)/54°C (blaGES)/56°C (blaVIM/OXA-48)/60°C (blaNDM-1) 40 sec, 72°C 1 min; 72°C 5 mins. PCR amplicons were electrophoretically separated (1.0–1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr), including 100 bp DNA ladder (Promega). Positive and negative control were used in each batch of reactions.

K. pneumoniae isolates were also screened for blaSHV, blaTEM, and blaCTX-M genes by Multiplex PCR assays, using previously described oligonucleotides and specific cycling conditions.11 The amplified products were resolved by agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) including a 100 bp DNA ladder (Promega) and controls in each batch of reactions.

Molecular Analysis of Colistin Resistance

The colistin-resistant (col-R) isolates were screened by singleplex PCRs for the presence of mcr-1,17 mcr-2,18 mcr-3,19 mcr-4,20 mcr-5,21 mcr-6,22 mcr-7,23 mcr-7.123 and mcr-8.22 Amplifications were performed in 25 μL volume using 2 μL DNA, 1X PCR master mix (Promega Corporation) and primers at 1 µM. Amplicons were characterized after agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) including a 100 bp DNA ladder (Promega).

PCR analysis of mgrB was performed using mgrB_Ext_F and mgrB_Ext_R primers targeting mgrB coding sequence and some flanking regions, as previously reported.13 Amplifications were carried out in 25 μL volume using 5 μL DNA template, 1X PCR master mix (Promega) and oligonucleotides at 2 µM.

Colistin-sensitive (col-S) strains were used as a negative control carrying wild-type mgrB. PCR products were characterised using agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) with a 100 bp DNA ladder (Promega). Amplicons longer than the expected molecular weight (253 bp) suggested the presence of an Insertion Sequence (IS), and were analyzed by Sanger sequencing (Eurofins Genomics, Germany GmbH, Ebersberg, Germany), including col-S strains as control. Sequences were analyzed with Basic Local Alignment Search Tool (BLAST; blast.ncbi.nlm.nih.gov/Blast.cgi) and processed with BioEdit v7.0.5.

The nucleotide sequences of wild-type mgrB in KP25 and KP42 isolates (GenBank Accession numbers MN389772 and MN389773, respectively), as well as those of col-R strains without ISs (KP5, KP6, KP7, KP9, KP10, KP28, KP31, KP34, KP36, KP39, KP40, KP41 and KP43) were deposited at BankIt/GenBank (Accession numbers: MN389775, MN389774, MN389776, MN389777, MN389778, MN389779, MN389780, MN389781, MN389782, MN389783, MN389784, MN389785, and MN389786, respectively).

To translate DNA sequences, EMBOSS Transeq () tool was used. The amino acid sequences were analyzed with Protein Variation Effect Analyzer (PROVEAN, ) allowing prediction by algorithm of the functional impact for all classes of sequence variations.30 The change in the alignment score was considered as a measure of change in similarity caused by variation and thus to protein functionality.

Molecular Typing by PFGE and MLST

For PFGE, bacterial DNA was digested with XbaI (Fermentas, Milan, Italy) according to PulseNet protocol using conditions of pulse times from 5 to 40 sec over 24 hrs at 6.0V/cm and at 14°C.31 Pulsotypes were analyzed through BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium), and dendrograms were generated using Dice coefficient and unweighted pair group method with arithmetic mean (UPGMA).9 The similarity band patterns interpretation was performed according to Tenover criteria,24,32 setting 85% and 95% similarity cut-off for identifying similar restriction patterns and clusters, respectively. A validated MLST scheme was used,33 and PCR products were sequenced by Sanger method (Eurofins Genomics) to identify allelic profiles and assign the Sequence Type (ST). The allelic combination was analysed on Pasteur platform ().

Results

Antimicrobial Resistance Profiles in K. pneumoniae Cultures

K. pneumoniae cultures showed a multi-carbapenem-resistant phenotype, with all resistant to ertapenem, 22 (84%) to meropenem, and 20 (77%) to imipenem. Twenty isolates were resistant to all carbapenems tested. In addition, nineteen (73%) strains were col-R. No isolates were susceptible to ampicillin, amoxicillin-clavulanate, ceftazidime, ciprofloxacin, cefotaxime, cefuroxime, levofloxacin, piperacillin and piperacillin-tazobactam. Moreover, 81% (n=21) isolates showed resistance to tobramycin, while 16 (62%) were resistant to trimethoprim, 16 (61.5%) to amikacin, 8 (31%) to tigecycline, 5 to gentamicin, and 2 to fosfomycin.

Prevalence of Resistance-Associated Genes

All K. pneumoniae harbored blaKPC, and 69.2% (n=18) were blaVIM positive. A high proportion of isolates also carried ESBLs. The blaSHV and blaTEM were found in 96.2% (n=25) and 88.4% (n=23), respectively, and 84.6% (n=22) harbored both genes. The blaCTX-M was only found in two strains. None of the strains carried blaGES, blaNDM-1 or blaOXA-48.

Prevalence of mcr Variants and mgrB Analysis

None of the 19 col-R isolates showed plasmid mcr-1,2,3,4,5,6,7,8 variants. Colistin resistance was also investigated through mgrB analysis, and the initial evaluation using agarose gel analysis, considering that the expected amplicon for wild-type mgrB has a 253 bp size.13 PCR products were sequenced to identify IS or mutations involved in colistin resistance.

Amplicons longer than the expected size were observed in six (31.6%) out of the 19 col-R isolates, and sequencing confirmed the presence of transposon. The most common insertion element detected in five cultures belonged to IS5-like family (1056 bp), while ISKpn14 element was found in KP11 (Figure 2). Furthermore, KP8, KP12, KP14, KP18 and KP19 isolates with IS5-like elements were all grouped in the PFGE cluster VIII.

Figure 2

Antimicrobials resistance phenotypes and antimicrobial resistance genes profiles for 26 K. pneumoniae isolates.

Abbreviations: col-S, colistin-sensitive; Δg19, deletion of guanine in position 19; V32G, Valine in position 32 is mutated in Glycine; T21N, Threonine in position 21 is mutated in Asparagine; W20stop, Tryptophan is mutated in stop codon; unknown, no mutation in mgrB gene.

In col-R strains with 253 bp amplicon, an identical deletion ∆g19 causing frameshift mutation and premature MgrB termination was found in KP9 and KP10 (n=2, 10.5%) isolates; missense mutations t95→g translated into V32G were found in 42.1% (n=8; KP5, KP31, KP34, KP36, KP40, KP41 and KP43) isolates; missense mutations c62→a translated as T21N occurred in KP28, as well as missense mutation g60→a translated into W20Stop was found in KP31 (Figures 3 and 4). After open reading frame identification, sequence analysis with PROVEAN was reported in Table 2.

Figure 3

Alignment of FASTA mgrB sequence in col-R K. pneumoniae without ISs compared with wild-type (WT) sequences in col-S isolates.

Notes: WT strains in blue; mutation highlighted in red.

Figure 4

FASTA alignment of MgrB amino acid sequence in col-R K. pneumoniae without ISs compared with wild-type (WT) sequence of col-S strains.

Notes: WT MgrB in col-S strains in light blue; non-functional MgrB without ISs in col-R strains in green; truncated MgrB in col-R strains in yellow.

Table 2

PROVEAN Analysis of the Single Amminoacid Change of MgrB Protein

Strain	Variant	Description	PROVEAN	Prediction
score	(cut off= −2.5)
KP5	V32G	Valine in position 32 is mutated in Glycine	−7	Deleterious
KP7
KP31
KP34
KP36
KP40
KP41
KP43
KP28	T21N	Threonine in position 21 is mutated in Asparagine	−3.23	Deleterious

Notes: Variants and their description are reported in the second and third columns, respectively. PROVEAN score is a measure of the change in protein structure: if the score is equal or below to the predefined threshold (cut off =−2.5), the variant is predicted to have a “deleterious” effect; if above, the variant is predicted to have a “neutral” effect.27 In the latter column, there is a prediction of the mutation effect on the protein functionality.

K. pneumoniae Molecular Epidemiology

PFGE revealed 12 clusters at 85% cut-off similarity (Figure 1): cluster VIII was the most common, grouping 9 (34.6%) isolates, followed by cluster V with three isolates, and clusters III, IV, and VI, each including two cultures. Dendrogram analysis at 95% similarity revealed 18 pulsotypes (PTs), with PT12 as the prevalent (n=4 isolates, 15.3%), followed by PT1, 3, 8 and PT10, each associated with two strains. PFGE discriminatory power was of 96%, as calculated by Simpson’s Index of Diversity.34

Figure 1

PFGE dendrogram (Dice coefficient) and MLST results for 26 clinical K. pneumoniae isolates.

Note: The new ST is highlighted in blue.

Abbreviation: ST, Sequence Type.

Three STs were identified (discriminatory power=0.61): the ST512 as the most common (n=13, 50%), followed by ST101 (n=10), and ST307 (n=2). It was not possible to define ST for KP10. ST512 was the most frequently detected during 2014–2015 (84.6%), while ST101 was the predominant during 2016–2017 (61.5%).

Discussion

The rapid spread of antibiotics resistance is nowadays a major concern causing untreatable infections in humans. A rising of MDR rate would lead to 10 million people dying every year by 2050, which exceeds the 8.2 million estimated deaths due to cancer.35

This study describes the AMR profiles and molecular epidemiological insights concerning colistin-resistant CR-Kp isolated during 2014–2017. K. pneumoniae were most commonly isolated from patients aged ≥60 years who were treated in the ICU, where invasive procedures with devices at risk of generating biofilms formation play a crucial role in the occurrence of CR-Kp.9,36,37

Twenty-one antimicrobial susceptibility patterns were found, underlining high inter-strain diversity. All cultures had an MDR pattern, with high percentages of carbapenem (76.9%) and colistin resistance (73%). Conversely, 92% of cultures were susceptible to fosfomycin, which has been recently evaluated for treating extensively drug-resistant (XDR) pathogens, although resistance associated to fosA gene is emerging and can be transferred between Enterobacteriaceae.38

The increased application of colistin therapy for infections due to MDR Gram-negative bacteria has contributed to the spread of transmissible resistance, and may speed up the progression from XDR to Pan-drug Resistant (PDR) Enterobacteriaceae.4,14,39 In our study, prevalence of col-R K. pneumoniae was higher than that reported in other Italian studies, ranging between 36.1% and 50%.9,40–42

Results regarding ESBLs presence are in line with other studies, where plasmid-acquired blaTEM and blaSHV were frequently associated with Klebsiella spp. infections.43,44 Conversely, blaCTX-M enzymes have become the most prevalent in E. coli, with potential to spread beyond the hospital environment in other species.45 The identification of ESBL-producing Klebsiella in hospital settings should be followed by infection control interventions, with reinforcement of hand hygiene of primary importance, followed by compliance with guidelines on antibiotic stewardship, and removal of contaminated devices.46

Concerning carbapenemases encoding genes, blaVIM and blaKPC genes were detected in 70% and 100% isolates, respectively, which is consistent with the endemic KPC circulation reported in Italy.5 Globally, the most worrying scenario is the increasing spread and dissemination of KPC-producing K. pneumoniae of clonal complex CC258 and CC512 being responsible for several outbreaks, unlike VIM carbapenemase, which is currently not widely diffused in Italy.8,47 Furthermore, K. pneumoniae producing NDM-1 or OXA-48 were not detected, similarly to IMP and GES, according to national data reporting sporadic cases.45

The increasing occurrence of col-R strains is considered a global concern. In Italy, a retrospective study (from January 2010 to June 2014) reported a threefold increase of colistin-resistance rate in KPC-producing K. pneumoniae in blood isolates, and 51% mortality at 30 days due to bloodstream infections.48

In our study, mcr-1,2,3,4,5,6,7,8 were not detected in col-R strains, which is consistent with previous reports,42 being more frequently detected in E. coli than in K. pneumoniae.49 Approximately 95% of col-R isolates carried alterations in mgrB, which is likely to be responsible for the colistin-resistant phenotypes. Inactivation of mgrB throughout ISs especially by IS5-like and ISKpn14 elements was detected in six out of 19 col-R strains. These mechanisms were reported elsewhere,13,16 and ISs transfer within genomes and plasmids has been considered a common driver of diversity and acquisition of antibiotic resistance.50 Furthermore, it has been reported that plasmids transfer between strains within the gut is a potential mechanism of indirect acquisition of colistin resistance.51 As assessed in vitro, IS interrupting mgrB and conferring colistin resistance was initially located on a plasmid.52

In three isolates, a truncated MgrB due to one single nucleotide deletion causing frameshift mutation and premature termination was found, as reported elsewhere.53 In addition, nine isolates had a non-functional MgrB due to one amino acid change (V32G, T21N and W20Stop), as observed in other studies.1,9,53 Hence, colistin resistance was linked to alterations in mgrB because complementation studies with a wild-type mgrB demonstrated that susceptibility to colistin can be successfully restored.53 In our study, col-R KP6 showed a wild-type mgrB, suggesting mutations in other colistin-resistance-related genes within Pmr signaling system or by alternative mechanism(s).

The presence of identical mgrB alterations in isolates from the same ward and assigned to the same ST and PFGE profile supports the clonal expansion and cross-transmission in hospital setting.53

PFGE revealed high level of strains diversity, and results from MLST indicated the circulation of ST512, ST101 and ST307. In the tested isolates, ST512, a single-locus variant of ST258, the most frequently detected clone responsible for KPC global spread,54 was the most common that is consistent with studies elsewhere in Italy.9,37,39 For KP10 strain, the ST was not assigned, being found a monoallelic variant of ST307 (4-1-1-52-1-1-7 instead of 4-1-2-52-1-1-7); thus, further analyses are needed to confirm the novel ST. Interestingly, MLST revealed that ST512 was the most frequently detected in 2014–2015, while ST101 prevailed during 2016–2017, suggesting a changed circulation in the latest years in our hospital. Remarkably, PFGE cluster VIII grouped 77% of col-R cultures, four of which isolated from patients within the ICU as indistinguishable pulsotypes, all carried transposons in mgrB and were isolated during Christmas season holidays (December 2014–January 2015). In particular, the cluster VIII included the cultures KP8 (isolation data 17/11/14), KP12 and KP14 (isolation data 12/1/14), and KP18 (isolation data 5/1/15) (Table 1), belonging to a group of strains isolated during an outbreak in the ICU ward, which was likely related to a low level of compliance to standard hygiene procedures because of reduced personnel availability, and underlined the likelihood of bacterial persistence in the hospital environment.10

The discriminatory abilities of PFGE and MLST were compared by the number of unique STs and number of clusters identified. PFGE showed good discriminatory power, and it is still considered a reference method for the epidemiological investigations of infectious diseases, including nosocomial outbreaks.55 PFGE, generating genome-wide DNA fingerprints with rare-cutter restriction enzymes, is also a cost-effective method; nevertheless, it is labor-intensive and may lack comparability between laboratories due to operator errors in identifying bands particularly when shifted or weak on PFGE gel image analysis. In our study, MLST was less discriminating than PFGE, as found elsewhere.24 Anyway, MLST is considered the most suitable genotyping method for strains comparison, further providing data within laboratories, and appropriate for global and long term or evolutionary studies rather than local epidemiology.55

Conclusions

To our knowledge, this is the first study concerning colistin and carbapenems resistance characteristics in clinical K. pneumoniae isolates from the Molise Region, central Italy. Although focusing on topic investigated elsewhere, our findings can be useful to better understand the most significant concerns on hospital infections by K. pneumoniae at a local level, and can support the molecular epidemiology data related to CR-Kp both nationally and internationally, hence contributing to complete the framework of the epidemiology of this microorganism.

This study confirms that CR-Kp infections are most commonly detected in ICU patients due to their critical conditions and invasive procedures like catheterization or tracheostomy. In our setting, the KPC enzyme remains the predominant carbapenemase in K. pneumoniae, followed by VIM. The highest prevalence of KPC was linked with ST512 prevalence, although a switching towards ST101 circulation was detected. A high level of colistin resistance was found, more than the rate reported in other studies, likely due to an overuse of colistin in our hospital setting, and it is associated with acquisition of insertion elements or accumulation of deleterious mutations in the mgrB gene. Further investigations are warranted to clarify the entire role of Pmr signaling system in col-R strains.

In conclusion, infections with carbapenem-resistant organisms, particularly when KPC-producing, are widely distributed, and antimicrobial treatments selected should be critically evaluated, since an optimal therapy is not yet defined.56 In light of the lack of novel antimicrobial agents for the treatment of difficult healthcare infections, the implementation of proper prevention strategies and adequate staffing is essential to control the spread of MDR K. pneumoniae.26 Moreover, the routine application of molecular analyses for rapid and accurate detection of determinants and mutations conferring resistance is crucial to reduce and control the burden of MDR bacterial infections40 and to guide best-choice therapy for better patient outcomes, as well as to elucidate epidemiology and dynamics of dissemination in the hospital environment.

Certainly, while, on one hand, not all the infections are associated with modifiable factors, evidences suggest that the spectrum of situations in which currently it is possible to intervene is broader than in the past. Furthermore, triggering and modifiable factors are mostly due to inadequate healthcare practices, particularly to the failure in applying standard and specific precautions for infectious diseases to avoid unnecessary procedures, the inappropriate use of antibiotics, and the lack of human and technological resources to be committed in the care and prevention.